Items where Author is "Vital, EM"

Journal article

ROBINSON, J.I., MD YUSOF, M.Y., DAVIES, V., WILD, D., MORGAN, M., TAYLOR, J.C., EL-SHERBINY, Y., MORRIS, D.L., LIU, L., RAWSTRON, A.C., BUCH, M.H., PLANT, D., CORDELL, H.J., ISAACS, J.D., BRUCE, I.N., EMERY, P., BARTON, A., VYSE, T.J., BARRETT, H., VITAL, E.M. and MORGAN, A.W., 2022. Comprehensive genetic and functional analyses of Fc gamma receptors influence on response to rituximab therapy for autoimmunity. EBioMedicine, 86: 104343. ISSN 2352-3964

YUSOF, M.Y.M., ROBINSON, J.I., DAVIES, V., WILD, D., MORGAN, M., TAYLOR, J.C., EL-SHERBINY, Y., MORRIS, D.L., LIU, L., RAWSTRON, A.C., BUCH, M.H., PLANT, D., CORDELL, H., ISAACS, J.D., BRUCE, I.N., EMERY, P., BARTON, A., VYSE, T.J., BARRETT, J.H., VITAL, E.M. and MORGAN, A.W., 2022. OA13 Comprehensive genetic and functional analyses of Fc gamma receptors explain response to rituximab therapy for autoimmune rheumatic diseases. Rheumatology, 61 (S1). ISSN 1462-0332

PONCHEL, F., CHURCHMAN, S.M., EL-JAWHARI, J.J., BURSKA, A.N., CHAMBERS, P., VITAL, E.M., EL-SHERBINY, Y.M., JONES, E., CONAGHAN, P.G., GOEB, V. and EMERY, P., 2021. Interleukin-7: a potential factor supporting B-cell maturation in the rheumatoid arthritis synovium. Clinical and Experimental Rheumatology, 39 (2), pp. 253-262. ISSN 0392-856X

EL‐SHERBINY, Y.M., YUSOF, M.Y.M., PSARRAS, A., HENSOR, E.M.A., KABBA, K.Z., DUTTON, K., MOHAMED, A.A.A., ELEWAUT, D., MCGONAGLE, D., TOOZE, R., DOODY, G., WITTMANN, M., EMERY, P. and VITAL, E.M., 2020. B cell tetherin: a flow‐cytometric cell‐specific assay for response to Type‐I interferon predicts clinical features and flares in SLE. Arthritis & Rheumatology, 72 (5), pp. 769-779. ISSN 2326-5191

EL-SHERBINY, Y.M., PSARRAS, A., MD YUSOF, M.Y., HENSOR, E.M.A., TOOZE, R., DOODY, G., MOHAMED, A.A.A., MCGONAGLE, D., WITTMANN, M., EMERY, P. and VITAL, E.M., 2018. A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical features. Scientific Reports, 8: 5793. ISSN 2045-2322

MD YUSOF, M.Y., PSARRAS, A., EL-SHERBINY, Y.M., HENSOR, E.M.A., DUTTON, K., UL-HASSAN, S., ZAYAT, A.S., SHALBAF, M., ALASE, A., WITTMANN, M., EMERY, P. and VITAL, E.M., 2018. Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status. Annals of the Rheumatic Diseases, 77 (10), pp. 1432-1439. ISSN 0003-4967

MD YUSOF, M.Y., SHAW, D., EL-SHERBINY, Y.M., DUNN, E., RAWSTRON, A.C., EMERY, P. and VITAL, E.M., 2017. Predicting and managing primary and secondary non-response to rituximab using B-cell biomarkers in systemic lupus erythematosus. Annals of the Rheumatic Diseases, 76 (11), pp. 1829-1836. ISSN 0003-4967

CARE, M.A., STEPHENSON, S.J., BARNES, N.A., FAN, I., ZOUGMAN, A., EL-SHERBINY, Y.M., VITAL, E.M., WESTHEAD, D.R., TOOZE, R.M. and DOODY, G.M., 2016. Network analysis identifies proinflammatory plasma cell polarization for secretion of ISG15 in human autoimmunity. The Journal of Immunology, 197 (4), pp. 1447-1459. ISSN 0022-1767

ALASE, A.A., EL-SHERBINY, Y.M., VITAL, E.M., TOBIN, D.J., TURNER, N.A. and WITTMANN, M., 2015. IFNλ stimulates MxA production in human dermal fibroblasts via a MAPK-dependent STAT1-independent mechanism. Journal of Investigative Dermatology, 135 (12), pp. 2935-2943. ISSN 0022-202X

DAS, S., VITAL, E.M., HORTON, S., BRYER, D., EL-SHERBINY, Y., RAWSTRON, A.C., PONCHEL, F., EMERY, P. and BUCH, M.H., 2014. Abatacept or tocilizumab after rituximab in rheumatoid arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy. Annals of the Rheumatic Diseases, 73 (5), pp. 909-912. ISSN 0003-4967

PONCHEL, F., GOËB, V., PARMAR, R., EL-SHERBINY, Y., BOISSINOT, M., EL JAWHARI, J., BURSKA, A., VITAL, E.M., HARRISON, S., CONAGHAN, P.G., HENSOR, E. and EMERY, P., 2014. An immunological biomarker to predict MTX response in early RA. Annals of the Rheumatic Diseases, 73 (11), pp. 2047-2053. ISSN 0003-4967